June 25, 2019 | City of Hope
City of Hope has accelerated its plans for a $1 billion comprehensive cancer campus in Orange County, bringing highly specialized cancer care, clinical trials, precision medicine and early detection to the nation’s sixth most populous county.
After multiple myeloma, recording artist plays on
December 18, 2018 | Zen Vuong
Seven City of Hope patients will welcome the New Year atop City of Hope’s 47th Rose Parade float, “Harmony of Hope.” Meet float rider Abraham Laboriel, a world-renowned bassist whose work has been featured in 4,000 recordings and film soundtracks, including “Coco,” “Frozen” and “Incredibles 2.”
New Briskin Center for Clinical Research opens at City of Hope
September 7, 2018 | Michael Easterling
By moving all of the clinical research services and staff to one place, we are enabling many of our patients to complete all of their clinical trial appointments in a single visit at a single location. The Briskin Center includes infusion areas, nursing stations, exam and procedure rooms, onsite pharmacy and lab services, a dedicated registration site and outdoor seating for patients and their families.
Students Today, Scientists Tomorrow: Interns Shine in the City of Hope Spotlight
September 6, 2017 | Michael Easterling
Students spent 10 weeks this summer at the Eugene and Ruth Roberts Summer Student Academy, designed to give hardworking students the opportunity to learn about science by working in a laboratory setting.
‘Dwindling’ ribs, failing kidneys: How one woman climbed back from myeloma
March 21, 2017 | Stephanie Smith
Hypercalcemia (high blood calcium), renal problems, anemia and bone problems, also known by the acronym, C.R.A.B. — reflects the typical symptoms of multiple myeloma. City of Hope follows a multiple myeloma patient, Donna McNutt, who finds ways to cope with her diagnosis.
ASH 2016: Groundbreaking new trials show promise for lymphoma and multiple myeloma patients
December 7, 2016 | City of Hope
Numerous clinical trials, which lay the groundwork for novel approaches to lymphoma and multiple myeloma therapies, could ultimately lead to new treatments that improve survival and quality of life for patients with those and other diseases. Additional studies give new insight into best practices for the treatment of various blood cancers.